AAAAAA
Results:
1-18
|
Results: 18
Authors:
BLOHMER JU
TULUSAN AH
JACKISCH C
KAUFMANN M
COSTA SD
VONMINCKWITZ G
EIERMANN W
Citation: Ju. Blohmer et al., DOSE INTENSIFIED PREOPERATIVE CHEMOTHERAPY WITH DOXORUBICIN DOCETAXELIN OPERABLE BREAST-CANCER - A PHASE-II TRIAL/, Annals of oncology, 9, 1998, pp. 33-33
Authors:
SCHROEDER W
LUCK HJ
THOMSSEN C
MOBUS V
KUHN W
VONMINCKWITZ G
UNTCH M
JACKISCH C
KOHLER G
Citation: W. Schroeder et al., PHASE III-MULTICENTER TRIAL EPIRUBICIN-PACLITAXEL VS. EPIRUBICIN-CYCLOPHOSPHAMIDE AS FIRST-LINE THERAPY OF METASTATIC BREAST-CANCER - AN AGO STUDY PROTOCOL, Annals of oncology, 9, 1998, pp. 560-560
Authors:
MOBUS V
SCHODER W
LUCK HJ
MEIER W
RICHTER B
WARM M
COSTA S
BAUKNECHT T
OLBRICHT S
NITZ U
JACKISCH C
DUBOIS A
Citation: V. Mobus et al., CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN OVARIAN-CANCER - AN AGO STUDY-GROUP PHASE-III TRIAL/, Annals of oncology, 9, 1998, pp. 661-661
Authors:
JACKISCH C
Citation: C. Jackisch, CURRENT DEVELOPMENTS IN THE APPLICATION OF DOCETAXEL (TAXOTERE(R)) INGYNECOLOGIC ONCOLOGY, Medizinische Klinik, 93(9), 1998, pp. 4-15
Authors:
KISTERS K
KORNER J
LOUWEN F
WITTELER R
JACKISCH C
ZIDEK W
OTT S
WESTERMANN G
BARENBROCK M
RAHN KH
Citation: K. Kisters et al., PLASMA AND MEMBRANE CA2-PREGNANCY AND IN PREECLAMPSIA( AND MG2+ CONCENTRATIONS IN NORMAL), Gynecologic and obstetric investigation, 46(3), 1998, pp. 158-163
Authors:
FRICK M
FISCHER J
NITZ U
ADOMEIT A
JACKISCH C
BENDER HG
WERNET P
Citation: M. Frick et al., INTRAINDIVIDUAL COMPARISON OF CD34-YIELD AFTER MOBILIZATION WITH G-CSF ALONE VERSUS CHEMOTHERAPY PLUS G-CSF, Bone marrow transplantation, 22, 1998, pp. 18-18
Authors:
BRANDT B
ROETGER A
HEIDL S
JACKISCH C
LELLE RJ
ASSMANN G
ZANKER KS
Citation: B. Brandt et al., ISOLATION OF BLOOD-BORNE EPITHELIUM-DERIVED C-ERBB-2 ONCOPROTEIN-POSITIVE CLUSTERED CELLS FROM THE PERIPHERAL-BLOOD OF BREAST-CANCER PATIENTS, International journal of cancer, 76(6), 1998, pp. 824-828
CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL - OPTIMIZING OF TREATMENT IN ADVANCED OVARIAN-CANCER/
Authors:
MOBUS V
JACKISCH C
LUCK HJ
MEIER W
BAUKNECHT T
COSTA S
RICHTER B
NITZ U
DUBOIS A
Citation: V. Mobus et al., CISPLATIN PACLITAXEL VS CARBOPLATIN/PACLITAXEL - OPTIMIZING OF TREATMENT IN ADVANCED OVARIAN-CANCER/, European journal of cancer, 33, 1997, pp. 531-531
Authors:
BRANDT BH
BECKMANN A
GEBHARDT F
ROTGER A
JACKISCH C
ASSMANN G
ZANKER KS
Citation: Bh. Brandt et al., TRANSLATIONAL RESEARCH STUDIES OF ERBB ONCOGENES - SELECTION-STRATEGIES FOR BREAST-CANCER-TREATMENT, Cancer letters, 118(2), 1997, pp. 143-151
Authors:
DUBOIS A
LUCK HJ
MEIER W
MOBUS V
COSTA S
RICHTER B
WARM M
BAUKNECHT T
SCHRODER W
OLBRICHT S
NITZ U
JACKISCH C
Citation: A. Dubois et al., CARBOPLATIN PACLITAXEL VERSUS CISPLATIN/PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN ADVANCED OVARIAN-CANCER - AN INTERIM ANALYSIS OF A RANDOMIZED PHASE-III TRIAL OF THE ARBEITSGEMEINSCHAFT GYNAKOLOGISCHE-ONKOLOGIE OVARIAN-CANCER STUDY-GROUP/, Seminars in oncology, 24(5), 1997, pp. 44-52
Authors:
DUBOIS A
LUCK HJ
MEIER W
MOBUS V
COSTA S
RICHTER B
BAUKNECHT T
WARM M
SCHROEDER W
OLBRICHT S
NITZ U
JACKISCH C
Citation: A. Dubois et al., CARBOPLATIN PLUS PACLITAXEL AS FIRST-LINE CHEMOTHERAPY IN PREVIOUSLY UNTREATED ADVANCED OVARIAN-CANCER, Seminars in oncology, 24(4), 1997, pp. 28-33
Authors:
PIZER ES
JACKISCH C
WOOD FD
PASTERNACK GR
DAVIDSON NE
KUHAJDA FP
Citation: Es. Pizer et al., INHIBITION OF FATTY-ACID SYNTHESIS INDUCES PROGRAMMED CELL-DEATH IN HUMAN BREAST-CANCER CELLS, Cancer research, 56(12), 1996, pp. 2745-2747
Authors:
RABER G
MEMPEL V
JACKISCH C
HUNDEIKER M
HEINECKE A
KURZL R
GLAUBITZ M
ROMPEL R
SCHNEIDER HPG
Citation: G. Raber et al., MALIGNANT-MELANOMA OF THE VULVA - REPORT OF 89 PATIENTS, Cancer, 78(11), 1996, pp. 2353-2358
Authors:
KLAASSEN U
KUHNDEL K
BAUKNECHT T
KUHNLE H
JACKISCH C
JONAT W
SCHULZE R
KAUFMANN M
MEIER W
VAHRSON H
WEISS J
WIEST W
URBANCZYK H
HERRMANN F
SCHILLER S
BALTZER J
JANICKE F
MOSNY DS
HECKER D
DIERGARTEN K
Citation: U. Klaassen et al., SAFETY AND EFFICACY OF TAXOL(R) (PACLITAXEL) OVER 3 H IN 306 PLATINUM-REFRACTORY PATIENTS WITH OVARIAN-CANCER - RESULTS OF A GERMAN COOPERATIVE STUDY, European journal of cancer, 31A, 1995, pp. 492-492
Authors:
BRANDT B
VOGT U
SCHLOTTER CM
JACKISCH C
WERKMEISTER R
THOMAS M
VONEIFF M
BOSSE U
ASSMANN G
ZANKER KS
Citation: B. Brandt et al., PROGNOSTIC RELEVANCE OF ABERRATIONS IN THE ERBB ONCOGENES FROM BREAST, OVARIAN, ORAL AND LUNG CANCERS - DOUBLE-DIFFERENTIAL POLYMERASE CHAIN-REACTION (DDPCR) FOR CLINICAL-DIAGNOSIS, Gene, 159(1), 1995, pp. 35-42
Authors:
LANGER D
JACKISCH C
Citation: D. Langer et C. Jackisch, RADICAL SUBCUTANEOUS MASTECTOMY - INDICAT ION AND TECHNIQUE FOR TUMOR-TARGETED BREAST-CONSERVING SURGICAL METHOD, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 544-545
Authors:
JACKISCH C
SCHEIDHAUER K
LOUWEN F
BRANDT B
LANGER D
SCHNEIDER HPG
Citation: C. Jackisch et al., RECEPTOR SCINTIGRAPHY WITH I-123 ESTRADIO L IN THE PRIMARY DIAGNOSIS OF BREAST-CANCER, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 782-783
Authors:
LOUWEN F
JACKISCH C
HOLZGREVE W
SCHNEIDER HPG
Citation: F. Louwen et al., COINCIDENCE OF RISK-FACTORS IN HELPP SYND ROME, Archives of gynecology and obstetrics, 254(1-4), 1993, pp. 1349-1351
Risultati:
1-18
|